BG1805

Guangzhou Bio-gene Technology Co., Ltd · Phase 1 active Biologic

At a glance

Generic name	BG1805
Sponsor	Guangzhou Bio-gene Technology Co., Ltd
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BG1805 CI brief — competitive landscape report
BG1805 updates RSS · CI watch RSS
Guangzhou Bio-gene Technology Co., Ltd portfolio CI